A Structural Shift, Not a Trend
For 20 years, risk adjustment in Medicare Advantage operated primarily as a revenue function. Find diagnoses. Submit codes. Increase RAF scores. Collect higher capitation payments. The clinical implications were an afterthought. Whether the coded conditions connected to actual patient care was someone else’s problem.
That era is ending. Not because plans suddenly prioritized patient outcomes over revenue, but because the enforcement environment changed. The DOJ collected $556M from Kaiser and $117.7M from Aetna in March 2026. OIG audits are finding error rates above 90% in sampled enrollee-years. CMS-HCC V28 eliminated thousands of codes and recalibrated the model to penalize coding intensity. Credit agencies are warning investors about MA profitability constraints tied directly to risk adjustment changes.
The financial incentive to overcode hasn’t disappeared, but the financial risk of overcoding has become real and quantifiable. And that changes the calculation for every health plan executive who has to sign off on risk adjustment strategy.
What ‘From Capture to Care’ Actually Means
The phrase sounds like marketing copy, but it describes a real operational shift happening across the industry. In the old model, risk adjustment sat in a silo. A vendor ran charts. Coders added codes. Revenue went up. Clinical teams didn’t know what was submitted on their patients. Providers never saw the output. There was no feedback loop between coding and care delivery, and no one asked whether the two aligned.
In the new model, risk adjustment integrates into clinical workflows. Conditions identified in chart reviews get routed back to providers for confirmation and ongoing management. Prospective tools surface unaddressed conditions before visits so providers can evaluate them in real time during the encounter. Post-visit reviews ensure documentation supports both accurate coding and active care plans. The coding function and the clinical function start talking to each other.
The difference matters because CMS increasingly examines whether submitted diagnoses connect to actual patient care. The OIG’s February 2026 guidance flagged diagnoses generated through health risk assessments that were never considered in patient care as high-risk practices. CMS doesn’t just want to see that a condition was coded. They want to see that it was managed. That’s a fundamentally different standard than what most programs were built to meet.
The Compliance Case for Clinical Integration
When risk adjustment and clinical operations are disconnected, predictable problems emerge. Codes get submitted for conditions no provider is treating. Charts show diagnoses with no follow-up care plans. Encounter data diverges from claim submissions. These patterns are the exact ones that trigger RADV audits, OIG investigations, and DOJ enforcement actions.
Clinical integration solves this at the root. When a diagnosis flows from a clinical encounter into coding and then into a care plan, every step creates documentation that reinforces the others. There’s a provider note, a coded claim, and a treatment plan that all align. An auditor reviewing that record sees consistency and clinical intent. An auditor reviewing a chart-mined code with no care plan attached sees exactly the kind of pattern regulators are targeting.
Plans that treat coding and clinical care as separate functions are building systems that look problematic by design, even if no one intended it that way. Plans that integrate them are building systems that look defensible by design. The difference shows up in audit outcomes, in legal exposure, and increasingly, in investor confidence.
Building for the Next Five Years
The plans that will perform best through 2030 and beyond are the ones building Prospective Risk Adjustment into their core operating model now. That means investing in provider-facing tools that improve documentation quality at the point of care. It means running two-way retrospective programs that clean and validate existing data instead of inflating it. It means treating every submitted code as something that must be provable, explainable, and connected to real patient care.
Risk adjustment is becoming a clinical discipline. The enforcement actions, model changes, and regulatory guidance of the past two years all point in one direction. The plans that treat it that way will outperform the ones still treating it as a revenue lever. And the gap between those two groups will only widen as CMS continues to tighten its audit processes and enforcement posture.